Skip links

Archive

Telephus Medical Announces Issuance of Japanese Patent for Anti-MRSA Antibodies

Telephus Medical Announces Issuance of Japanese Patent for Anti-MRSA Antibodies

in

Telephus Medical LLC (Telephus), a biotechnology company focused on development of antibody therapies for antibiotic-resistant staphylococcal infections, today announced that the Japan Patent Office has issued Japanese patent number 5,837,215 covering monoclonal antibody compositions that bind and neutralize the endo-β-Nacetylglucosaminidase (Gmd) subunit of staphylococcal bifunctional

Rochester Researcher Collaborates to Create Temporary Skin Substitute Resistant to Scarring

Rochester Researcher Collaborates to Create Temporary Skin Substitute Resistant to Scarring

in

Richard Phipps, Ph.D., Professor of Environmental Medicine, is collaborating with Aubrey Woodroof, Ph.D. (founder of PermeaDerm, Inc., and inventor of the first bilaminate, biosynthetic, temporary wound dressing, Biobrane®), and BioDot, Inc. (a leader in the field of dispensing low volumes of fluids and powders) to